China's ‘dynamic zero COVID-19 strategy’ will face greater challenges in the future - 09/06/22
Doi : 10.1016/j.jinf.2022.04.025
Juncheng Cai a, b, c, d, Siyuan Hu e, Qiuyan Lin a, b, c, d, Tao Ren a, b, c, d, ⁎ 
, Libin Chen a, b, c, d, ⁎
, Libin Chen a, b, c, d, ⁎ a College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China
b Key Laboratory of Animal Vaccine Development, Ministry of Agriculture and Rural Affairs, Guangzhou, China
c National and Regional Joint Engineering Laboratory for Medicament of Zoonosis Prevention and Control, Guangzhou, China
d Key Laboratory of Zoonosis Prevention and Control of Guangdong Province, Guangzhou, China
e School of Advanced International Studies, Johns Hopkins University, Baltimore, United States
⁎Corresponding authors at: College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.College of Veterinary Medicine, South China Agricultural UniversityGuangzhou 510642China
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
© 2022
Publié par Elsevier Masson SAS.
Vol 85 - N° 1
P. e13-e14 - juillet 2022 Retour au numéro
Article précédent
- Lack of efficacy for sotrovimab use in patients with COVID-19: A meta-analysis
- Guangyu Ao, Toni Li, Yushu Wang, Carolyn Tran, Xin Qi
- A case of breakthrough infection with SARS-CoV-2 Delta derivative and reinfection with Omicron variant in a fully vaccinated health care professional
- Priyanka Pandit, Puneet Bhatt, Rima R. Sahay, Yash Joshi, Deepak Y. Patil, Pragya D. Yadav
Bienvenue sur EM-consulte, la référence des professionnels de santé.